CEO
Rich joined Babraham Research Campus in 2026 from LBIC (London Bioscience Innovation Centre Ltd), a subsidiary of the Royal Veterinary College and key provider of innovation space and support services for early and growth stage life science companies in London’s vibrant Knowledge Quarter. During his tenure as CEO, Rich led the expansion of LBIC in King’s Cross, doubling the Centre’s footprint. The organisation went on to win the One Nucleus award for Outstanding Contribution to Life Sciences in 2025 during its 25th anniversary year.
Prior to LBIC, Rich spent three years at University College Cork (UCC) as Director of Innovation, responsible for technology transfer, entrepreneurship, consultancy and incubation; further to 18 years at the University of Manchester culminating in the role of Director of Operations for its subsidiary innovation company.
Rich’s early career was with AstraZeneca Diagnostics where he held a variety of scientific and business development roles before leading its international sales & marketing function.
Passionate about driving life science innovation, shaping the future of biotech entrepreneurship and supporting the growth of dynamic life science companies, Rich holds a BSc (Hons) in Biochemistry (Sussex) and a PhD in molecular biology from Reading.